The databases indicated that, despite the aforementioned, patients with ER-positive breast cancer had greater levels of FLRT2 gene expression, and it was positively correlated with ESR2 gene expression in Basal and Luminal A breast cancer patients. The gene discussed is FLRT2; the disease is breast carcinoma.